Protocol No. PTC124 GD 020 DMD entitled, A Phase 3 Effic

Project: Research project

Project Details

Description

Protocol No. PTC124 GD 020 DMD entitled, A Phase 3 Efficacy and Safety Study of Ataluren in Patients with Nonsense Mutation Dystrophinopathy
StatusFinished
Effective start/end date6/12/1312/31/17

Funding

  • PTC Therapeutics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.